Bicara Therapeutics Inc.

BCAX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Jun 16, 2025
8-K Jun 12, 2025 8-K
4 Jun 10, 2025 FORM 4
4 Jun 10, 2025
4 Jun 10, 2025 FORM 4
4 Jun 10, 2025 FORM 4
4 Jun 10, 2025 FORM 4
4 Jun 10, 2025 FORM 4
4 Jun 10, 2025 FORM 4
4 Jun 10, 2025 FORM 4
8-K Jun 6, 2025 8-K
SCHEDULE 13G May 15, 2025
10-Q May 13, 2025 10-Q
8-K May 13, 2025 8-K
SCHEDULE 13G/A May 12, 2025
ARS Apr 25, 2025 ARS
DEFA14A Apr 25, 2025 DEFA14A
DEF 14A Apr 25, 2025 DEF 14A
S-8 Mar 28, 2025 S-8
10-K Mar 27, 2025 10-K
8-K Mar 27, 2025 8-K
4 Mar 18, 2025 4
144 Mar 14, 2025
SCHEDULE 13G Mar 3, 2025
SCHEDULE 13G/A Feb 12, 2025
← Newer Page 8 of 11 · 263 filings Older →